184 related articles for article (PubMed ID: 38082261)
21. Protective effects of combination of Stauntonia hexaphylla and Cornus officinalis on testosterone-induced benign prostatic hyperplasia through inhibition of 5α- reductase type 2 and induced cell apoptosis.
Karunasagara S; Hong GL; Jung DY; Kim KH; Cho K; Jung JY
PLoS One; 2020; 15(8):e0236879. PubMed ID: 32790676
[TBL] [Abstract][Full Text] [Related]
22. Methyl Jasmonate Ameliorates Testosterone Propionate-induced Prostatic Hyperplasia in Castrated Wistar Rats.
Akanni OO; Abiola OJ; Adaramoye OA
Phytother Res; 2017 Apr; 31(4):647-656. PubMed ID: 28211173
[TBL] [Abstract][Full Text] [Related]
23. Linh Phu Khang Tue Tinh inhibited prostate proliferation in rats induced benign prostatic hyperplasia by testosterone propionate.
Minh TD; Thanh Ha TN; Duy TN; Hoang NN; PhamTien D; Thai HP; Thi HN; Thi Lan PD; Quoc BP; Ivkin DY; Povydysh MN; Cong BN; Krasnova MV
J Ethnopharmacol; 2021 Oct; 279():114388. PubMed ID: 34224813
[TBL] [Abstract][Full Text] [Related]
24. A phytosterol-enriched saw palmetto supercritical CO
Sudeep HV; Venkatakrishna K; Amrutharaj B; Anitha ; Shyamprasad K
BMC Complement Altern Med; 2019 Oct; 19(1):270. PubMed ID: 31623582
[TBL] [Abstract][Full Text] [Related]
25. Inhibitory Effect of Thymoquinone on Testosterone-Induced Benign Prostatic Hyperplasia in Wistar Rats.
Al-Trad B; Al-Zoubi M; Qar J; Al-Batayneh K; Hussien E; Muhaidat R; Aljabali A; Alkhateeb H; Al Omari G
Phytother Res; 2017 Dec; 31(12):1910-1915. PubMed ID: 28960541
[TBL] [Abstract][Full Text] [Related]
26. Berberine ameliorates testosterone-induced benign prostate hyperplasia in rats.
Shabani E; Kalantari H; Kalantar M; Goudarzi M; Mansouri E; Kalantar H
BMC Complement Med Ther; 2021 Dec; 21(1):301. PubMed ID: 34930229
[TBL] [Abstract][Full Text] [Related]
27. Safety and efficacy of a novel Prunus domestica extract (Sitoprin, CR002) on testosterone-induced benign prostatic hyperplasia (BPH) in male Wistar rats.
Swaroop A; Bagchi M; Kumar P; Preuss HG; Bagchi D
Toxicol Mech Methods; 2015; 25(9):653-64. PubMed ID: 26337762
[TBL] [Abstract][Full Text] [Related]
28. A new experimental rat model of erectile dysfunction and lower urinary tract symptoms associated with benign prostatic hyperplasia: the testosterone-supplemented spontaneously hypertensive rat.
Oudot A; Oger S; Behr-Roussel D; Caisey S; Bernabé J; Alexandre L; Giuliano F
BJU Int; 2012 Nov; 110(9):1352-8. PubMed ID: 22448674
[TBL] [Abstract][Full Text] [Related]
29. Chemical profiles of the active fraction from Prinsepia utilis Royle leaves and its anti-benign prostatic hyperplasia evaluation in animal models.
Peng Y; Peng C; Wu Y; Sun C; Li X
BMC Complement Med Ther; 2021 Oct; 21(1):272. PubMed ID: 34715848
[TBL] [Abstract][Full Text] [Related]
30. Potential of telmisartan in the treatment of benign prostatic hyperplasia.
Ishola IO; Anunobi CC; Tijani KH; Afolayan O; Udokwu VU
Fundam Clin Pharmacol; 2017 Dec; 31(6):643-651. PubMed ID: 28727906
[TBL] [Abstract][Full Text] [Related]
31. Role of PPAR-α agonist fenofibrate in the treatment of induced benign prostatic hyperplasia with dysplastic changes in rats.
Refaie MMM; Rifaai RA; Zenhom NM
Fundam Clin Pharmacol; 2018 Dec; 32(6):617-626. PubMed ID: 29862557
[TBL] [Abstract][Full Text] [Related]
32. Diacerein provokes apoptosis, improves redox balance, and downregulates PCNA and TNF-α in a rat model of testosterone-induced benign prostatic hyperplasia: A new non-invasive approach.
Rasheed RA; Sadek AS; Khattab RT; Elkhamisy FAA; Abdelfattah HA; Elshaer MMA; Almutairi SM; Hussein DS; Embaby AS; Almoatasem MAM
PLoS One; 2023; 18(11):e0293682. PubMed ID: 37943844
[TBL] [Abstract][Full Text] [Related]
33. Inhibitory Effect of Artemisinin on Testosterone Propionate Induced Benign Prostatic Hyperplasia.
Solanki A; Patel S; Solanki N; Shah U
Curr Drug Discov Technol; 2021; 18(4):518-524. PubMed ID: 32532194
[TBL] [Abstract][Full Text] [Related]
34.
Kim M; Tran P; Yin J; Song J; Kim H
Nutrients; 2023 Feb; 15(4):. PubMed ID: 36839177
[TBL] [Abstract][Full Text] [Related]
35. Febuxostat attenuates testosterone-induced benign prostatic hyperplasia in rats via inhibiting JAK/STAT axis.
Abo-Youssef AM; Afify H; Azouz AA; Abdel-Rahman HM; Abdel-Naim AB; Allam S
Life Sci; 2020 Nov; 260():118414. PubMed ID: 32926929
[TBL] [Abstract][Full Text] [Related]
36. Effects of Melandrium firmum methanolic extract on testosterone-induced benign prostatic hyperplasia in Wistar rats.
Lee MY; Shin IS; Seo CS; Lee NH; Ha HK; Son JK; Shin HK
Asian J Androl; 2012 Mar; 14(2):320-4. PubMed ID: 22231294
[TBL] [Abstract][Full Text] [Related]
37. Atorvastatin attenuates testosterone-induced benign prostatic hyperplasia in rats: role of peroxisome proliferator-activated receptor-γ and cyclo-oxygenase-2.
Ishola IO; Tijani HK; Dosumu OO; Anunobi CC; Oshodi TO
Fundam Clin Pharmacol; 2017 Dec; 31(6):652-662. PubMed ID: 28636803
[TBL] [Abstract][Full Text] [Related]
38. Preventive effects of lignan extract from flax hulls on experimentally induced benign prostate hyperplasia.
Bisson JF; Hidalgo S; Simons R; Verbruggen M
J Med Food; 2014 Jun; 17(6):650-6. PubMed ID: 24460407
[TBL] [Abstract][Full Text] [Related]
39. Curcuma oil ameliorates benign prostatic hyperplasia through suppression of the nuclear factor-kappa B signaling pathway in rats.
Wang S; Li Y; Li W; Zhang K; Yuan Z; Cai Y; Xu K; Zhou J; Du Z
J Ethnopharmacol; 2021 Oct; 279():113703. PubMed ID: 33340599
[TBL] [Abstract][Full Text] [Related]
40. Effects of Saussurea costus on apoptosis imbalance and inflammation in benign prostatic hyperplasia.
Choi DH; Kim JY; An JH; Sung SH; Kong HS
J Ethnopharmacol; 2021 Oct; 279():114349. PubMed ID: 34171398
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]